Principal Investigator

Glenn J
Awardee Organization

Wake Forest University Health Sciences
United States

Fiscal Year
Activity Code
Early Stage Investigator Grants (ESI)
Not Applicable
Project End Date

Wake Forest NCORP Research Base

The overarching goal of the Wake Forest NCORP Cancer Center Research Base (WF NCORP RB) is to improve patient well-being and the quality of cancer care by developing, implementing and successfully completing innovative and feasible Cancer Control and Cancer Care Delivery (CCDR) clinical research studies. For nearly two decades as a CCOP and now NCORP Research Base, Wake Forest has maintained an exclusive focus on Cancer Control and CCDR studies and has emphasized efficient operational processes and extensive interactions with our NCORP Community Site and Minority Underserved Community Site partners. During the first 4 years of the NCORP network, the WF NCORP RB: opened 7 Cancer Control and 3 CCDR studies; enrolled 1,140 participants on WF NCORP RB studies; obtained approval for 5 additional concepts and protocols bringing the total remaining and planned accrual for active and pending trials to over 4,420 participants; and achieved a 33% accrual rate of racial/ethnic minority participants, as well as 68% women, 14% rural residents and 26% age 65 or greater. Over the next 6 years, we will build on and strengthen this highly successful platform by accomplishing the following Specific Aims: Specific Aim 1: Extend our cancer control clinical research activities in the following areas: cardiovascular complications of cancer therapy; radiation and chemotherapy-induced neurocognitive toxicities; and additional cancer and treatment-related symptoms and related-outcomes prioritized by NCI steering committees and those commonly associated with novel emerging treatment paradigms. Specific Aim 2: Elucidate and intervene upon patient, family, clinician, and organizational factors that influence cancer care delivery, emphasizing survivorship care, informal cancer caregivers and implementation of evidence-based supportive care services. Specific Aim 3: Illuminate biological mechanisms underlying cancer and treatment-related symptoms and toxicities in new and innovative multidisciplinary collaborative studies taking advantage of our growing biobank of blood, urine and salivary fluid specimens. Specific Aim 4: Identify and address determinants of cancer disparities via disparities-focused studies, integrated aims focused on underserved populations, and targeted recruitment of racial and ethnic minority and underserved populations across all Wake Forest NCORP research investigations. Specific Aim 5: Train the next generation of Cancer Control and CCDR researchers through mentoring and involvement of early career faculty, oncology trainees, post-doctoral fellows, and students in WF NCORP activities. Our ongoing and proposed Cancer Control and CCDR studies will continue to improve oncology care by informing best practices for symptom and late effect management as well as efficient, patient-centered, evidence-based cancer care delivery for diverse patient populations. In the next funding period, the WF NCORP RB will help accelerate the translation of knowledge in cancer control and cancer care delivery through close partnership with community and minority underserved sites and studies designed for future dissemination and implementation.


  • Suddala S, O'Connell N, D'Agostino R Jr, Ladd A, Lucas AR, Jordan JH, Salloum FN, Ky B, Hackney MH, Hundley WG. Reduced Thoracic Aortic Distensibility Upon Breast Cancer Diagnosis (WF-97415 and WF-98213). JACC. CardioOncology. 2023 Mar 7;5(5):704-706. doi: 10.1016/j.jaccao.2022.11.018. eCollection 2023 Oct. PMID: 37969653
  • Bhatnagar B, Kohlschmidt J, Mrózek K, Zhao Q, Fisher JL, Nicolet D, Walker CJ, Mims AS, Oakes C, Giacopelli B, Orwick S, Boateng I, Blachly JS, Maharry SE, Carroll AJ, Powell BL, Kolitz JE, Stone RM, Byrd JC, Paskett ED, de la Chapelle A, Garzon R, Eisfeld AK. Poor Survival and Differential Impact of Genetic Features of Black Patients with Acute Myeloid Leukemia. Cancer discovery. 2021 Mar;11(3):626-637. Epub 2020 Dec 4. PMID: 33277314
  • Foley KL, Dressler EV, Weaver KE, Sutfin EL, Miller DP Jr, Bellinger C, Kittel C, Stone RJ, Petty WJ, Land SR, Spangler JG, Lesser GJ, Chiles C, Optimizing Lung Screening Trial Writing Team. The Optimizing Lung Screening Trial (WF-20817CD): Multicenter Randomized Effectiveness Implementation Trial to Increase Tobacco Use Cessation for Individuals Undergoing Lung Screening. Chest. 2023 Aug;164(2):531-543. Epub 2023 Mar 15. PMID: 36931460
  • Sachs BC, Gaussoin SA, Brenes GA, Casanova R, Chlebowski RT, Chen JC, Luo J, Rapp SR, Shadyab AH, Shumaker S, Wactawski-Wende J, Wells GL, Hayden KM. The relationship between optimism, MCI, and dementia among postmenopausal women. Aging & mental health. 2023 Jun;27(6):1208-1216. Epub 2022 Jun 11. PMID: 35694859
  • Mabudian L, D'Agostino RB Jr, Jordan JH, Martin MB, Fleshman JA, Crotts T, Ladd A, Olson K, Weaver KE, Hackney MH, Hundley WG. Accuracy of Rapid Cardiovascular Magnetic Resonance Assessment of Left Ventricular Function During Community Cancer Cardiotoxicity Surveillance (WF98213). The American journal of cardiology. 2023 Oct 15;205:204-206. Epub 2023 Aug 21. PMID: 37611411
  • Bhatnagar B, Kohlschmidt J, Orwick SJ, Buelow DR, Fobare S, Oakes CC, Kolitz JE, Uy G, Stock W, Powell BL, Nicolet D, Hertlein EK, Mrózek K, Blachly JS, Eisfeld AK, Baker SD, Byrd JC. Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study. Blood advances. 2023 Aug 22;7(16):4671-4675. PMID: 37603350
  • Cadham CJ, Cao P, Jayasekera J, Taylor KL, Levy DT, Jeon J, Elkin EB, Foley KL, Joseph A, Kong CY, Minnix JA, Rigotti NA, Toll BA, Zeliadt SB, Meza R, Mandelblatt J, CISNET-SCALE Collaboration, Cadham CJ, Cao P, Jayasekera J, Taylor KL, Levy DT, Jeon J, Meza R, Mandelblatt J. Cost-Effectiveness of Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Simulation Study. Journal of the National Cancer Institute. 2021 Aug 2;113(8):1065-1073. PMID: 33484569
  • Hundley WG, D'Agostino R Jr, Crotts T, Craver K, Hackney MH, Jordan JH, Ky B, Wagner LI, Herrington DM, Yeboah J, Reding KW, Ladd AC, Rapp SR, Russo S, O'Connell N, Weaver KE, Dressler EV, Ge Y, Melin SA, Gudena V, Lesser GJ. Statins and Left Ventricular Ejection Fraction Following Doxorubicin Treatment. NEJM evidence. 2022 Sep;1. (9). Epub 2022 Aug 18. PMID: 36908314
  • Davis TC, Arnold CL, Mills G, Lesser GJ, Brown WM, Schulz R, Weaver KE, Pawloski PA. Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study. International journal of environmental research and public health. 2021 Oct 21;18. (21). PMID: 34769563
  • Vitolins MZ, Case LD, Rapp SR, Lively MO, Shaw EG, Naughton MJ, Giguere J, Lesser GJ. Self-reported adherence and biomarker levels of CoQ10 and alpha-tocopherol. Patient preference and adherence. 2018 Apr 24;12:637-646. doi: 10.2147/PPA.S158682. eCollection 2018. PMID: 29731611
  • Foraker RE, Davidson EC, Dressler EV, Wells BJ, Lee SC, Klepin HD, Winkfield KM, Hundley WG, Payne PRO, Lai AM, Lesser GJ, Weaver KE. Addressing cancer survivors' cardiovascular health using the automated heart health assessment (AH-HA) EHR tool: Initial protocol and modifications to address COVID-19 challenges. Contemporary clinical trials communications. 2021 Jun 16;22:100808. doi: 10.1016/j.conctc.2021.100808. eCollection 2021 Jun. PMID: 34189339
  • Park ER, Chiles C, Cinciripini PM, Foley KL, Fucito LM, Haas JS, Joseph AM, Ostroff JS, Rigotti NA, Shelley DR, Taylor KL, Zeliadt SB, Toll BA, Smoking Cessation at Lung Examination (SCALE) Research Group. Impact of the COVID-19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer. 2021 Feb 1;127(3):334-338. Epub 2020 Oct 13. PMID: 33048350
  • Hundley WG, Jordan JH. When Left Ventricular Extracellular Volume Fraction Changes After Anthracyclines: Is it Due to a Change in the Numerator, Denominator, or Both? JACC. Cardiovascular imaging. 2018 Aug;11(8):1056-1058. PMID: 30092966
  • Minasian L, Dimond E, Davis M, Adhikari B, Fagerstrom R, Fabian C, Floyd J, Unger JM, Douglas PS, Mustian KM, Chow EJ, Lipshultz S, Hundley WG, Armenian S, Ky B. The Evolving Design of NIH-Funded Cardio-Oncology Studies to Address Cancer Treatment-Related Cardiovascular Toxicity. JACC. CardioOncology. 2019 Sep;1(1):105-113. Epub 2019 Sep 24. PMID: 32529192
  • Fu H, Nicolet D, Mrózek K, Stone RM, Eisfeld AK, Byrd JC, Archer KJ. Controlled variable selection in Weibull mixture cure models for high-dimensional data. Statistics in medicine. 2022 Sep 30;41(22):4340-4366. Epub 2022 Jul 6. PMID: 35792553
  • Nightingale CL, Sterba KR, McLouth LE, Kent EE, Dressler EV, Dest A, Snavely AC, Adonizio CS, Wojtowicz M, Neuman HB, Kazak AE, Carlos RC, Hudson MF, Unger JM, Kamen CS, Weaver KE. Caregiver engagement practices in National Cancer Institute Clinical Oncology Research Program settings: Implications for research to advance the field. Cancer. 2021 Feb 15;127(4):639-647. Epub 2020 Nov 2. PMID: 33136296
  • Jordan JH, Todd RM, Vasu S, Hundley WG. Cardiovascular Magnetic Resonance in the Oncology Patient. JACC. Cardiovascular imaging. 2018 Aug;11(8):1150-1172. PMID: 30092971
  • Gifford AR, Lawrence JA, Baker LD, Balcueva EP, Case D, Craft S, Curtis AE, Griffin L, Groteluschen DL, Klepin HD, Lesser GJ, Messino MJ, Naughton M, Samuel TA, Rapp S, Sachs B, Sink KM, Williamson J, Shaw EG. National Institute on Aging /Alzheimer's Association criteria for Mild Cognitive Impairment applied to chemotherapy treated breast cancer survivors. Journal of oncology research. 2017;1. (1). Epub 2017 Oct 20. PMID: 29873324
  • Danhauer SC, Dressler EV, Brown WM, Nightingale CL, Brenes GA, Petty WJ, Curtis A, Murkutla S, Huang J, Wagi CR, Lesser GJ, Weaver KE. Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-Treatment Lung Cancer Survivors at Community Cancer Clinics (WF-01213). Integrative cancer therapies. 2023 Jan-Dec;22:15347354231164406. PMID: 37029555
  • Jordan JH, D'Agostino RB Jr, Avis NE, Mihalko SL, Brubaker PH, Kitzman D, Winkfield KM, Suerkin CK, Reding KW, Klepin HD, Lesser GJ, Hundley WG. Fatigue, Cardiovascular Decline, and Events after Breast Cancer Treatment: Rationale and Design of UPBEAT Study. JACC. CardioOncology. 2020 Mar 17;2(1):114-118. doi: 10.1016/j.jaccao.2020.02.013. eCollection 2020 Mar. PMID: 34396215
  • Eisfeld AK, Kohlschmidt J, Mims A, Nicolet D, Walker CJ, Blachly JS, Carroll AJ, Papaioannou D, Kolitz JE, Powell BE, Stone RM, de la Chapelle A, Byrd JC, Mrózek K, Bloomfield CD. Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years. Leukemia. 2020 Dec;34(12):3215-3227. Epub 2020 May 27. PMID: 32461631
  • Cramer CK, Alphonse-Sullivan N, Isom S, Metheny-Barlow LJ, Cummings TL, Page BR, Brown DR, Blackstock AW Jr, Peiffer AM, Strowd RE, Rapp S, Lesser GJ, Shaw EG, Chan MD. Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial. Journal of cancer research and clinical oncology. 2019 Feb;145(2):337-344. Epub 2018 Nov 12. PMID: 30417218
  • Cramer CK, McKee N, Case LD, Chan MD, Cummings TL, Lesser GJ, Shaw EG, Rapp SR. Mild cognitive impairment in long-term brain tumor survivors following brain irradiation. Journal of neuro-oncology. 2019 Jan;141(1):235-244. Epub 2018 Nov 7. PMID: 30406339
  • Rapp SR, Case LD, Peiffer A, Naughton MM, Chan MD, Stieber VW, Moore DF Jr, Falchuk SC, Piephoff JV, Edenfield WJ, Giguere JK, Loghin ME, Shaw EG. Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 May 20;33(15):1653-9. Epub 2015 Apr 20. PMID: 25897156
  • Ellis SD, Vaidya R, Unger JM, Stratton K, Gills J, Van Veldhuizen P, Mederos E, Dressler EV, Hudson MF, Kamen C, Neuman HB, Kazak AE, Carlos RC, Weaver KE. Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey. Contemporary clinical trials communications. 2022 Aug 14;29:100981. doi: 10.1016/j.conctc.2022.100981. eCollection 2022 Oct. PMID: 36033360
  • Loh KP, Wang Y, Yilmaz S, Nightingale CL, Parsons SK, Braun-Inglis C, Gada U, Montes A, Magnuson A, Culakova E, Strause S, Kamen C, Dressler E, Mustian K, Morrow G, Mohile S, Landscape Committee. Information Technology and Telemedicine Services in Community Oncology Practices. JCO clinical cancer informatics. 2023 Aug;7:e2300086. PMID: 37540817
  • Aaron RV, Finan PH, Wegener ST, Keefe FJ, Lumley MA. Emotion regulation as a transdiagnostic factor underlying co-occurring chronic pain and problematic opioid use. The American psychologist. 2020 Sep;75(6):796-810. PMID: 32915024
  • Brastianos PK, Twohy E, Geyer S, Gerstner ER, Kaufmann TJ, Tabrizi S, Kabat B, Thierauf J, Ruff MW, Bota DA, Reardon DA, Cohen AL, De La Fuente MI, Lesser GJ, Campian J, Agarwalla PK, Kumthekar P, Mann B, Vora S, Knopp M, Iafrate AJ, Curry WT Jr, Cahill DP, Shih HA, Brown PD, Santagata S, Barker FG 2nd, Galanis E. BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas. The New England journal of medicine. 2023 Jul 13;389(2):118-126. PMID: 37437144
  • DeMari JA, Dressler EV, Foraker RE, Wells BJ, Smith S, Klepin H, Hundley WG, Lesser GJ, Shalowitz DI, Nightingale CL, Hernandez M, Weaver KE. Endometrial cancer survivors' perceptions of their cardiovascular disease risk (results from WF-1804CD AH-HA). Gynecologic oncology. 2023 Jul;174:208-212. Epub 2023 May 22. PMID: 37224793
  • Cramer CK, Cummings TL, Andrews RN, Strowd R, Rapp SR, Shaw EG, Chan MD, Lesser GJ. Treatment of Radiation-Induced Cognitive Decline in Adult Brain Tumor Patients. Current treatment options in oncology. 2019 Apr 8;20(5):42. PMID: 30963289
  • Salz T, Ostroff JS, Nightingale CL, Atkinson TM, Davidson EC, Jinna SR, Kriplani A, Lesser GJ, Lynch KA, Mayer DK, Oeffinger KC, Patil S, Salner AL, Weaver KE. The Head and Neck Survivorship Tool (HN-STAR) Trial (WF-1805CD): A protocol for a cluster-randomized, hybrid effectiveness-implementation, pragmatic trial to improve the follow-up care of head and neck cancer survivors. Contemporary clinical trials. 2021 Aug;107:106448. Epub 2021 May 21. PMID: 34023515
  • Rebechi M, Kohlschmidt J, Mrózek K, Nicolet D, Mims AS, Blachly JS, Orwick S, Larkin KT, Oakes CC, Hantel A, Carroll AJ, Blum WG, Powell BL, Uy GL, Stone RM, Larson RA, Byrd JC, Paskett ED, Plascak JJ, Eisfeld AK. Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood advances. 2023 Aug 8;7(15):4019-4023. PMID: 37196637
  • Bellinger C, Foley KL, Dressler EV, Kittel C, Miller DP Jr, Weaver KE, Sutfin EL, Petty WJ, Spangler J, Stone R, Anderson DM, Kehn H, Steenstra C, Panikkar R, Chiles C, Study Writing Team. Organizational Characteristics and Smoking Cessation Support in Community-Based Lung Cancer Screening Programs. Journal of the American College of Radiology : JACR. 2022 Apr;19(4):529-533. Epub 2022 Mar 2. PMID: 35247325
  • Russler-Germain DA, Krysiak K, Ramirez C, Mosior M, Watkins MP, Gomez F, Skidmore ZL, Trani L, Gao F, Geyer S, Cashen AF, Mehta-Shah N, Kahl BS, Bartlett NL, Alderuccio JP, Lossos IS, Ondrejka SL, Hsi ED, Martin P, Leonard JP, Griffith M, Griffith OL, Fehniger TA. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303. Blood advances. 2023 Sep 26;7(18):5524-5539. PMID: 37493986
  • Hu JJ, Urbanic JJ, Case LD, Takita C, Wright JL, Brown DR, Langefeld CD, Lively MO, Mitchell SE, Thakrar A, Bryant D, Baglan K, Strasser J, Baez-Diaz L, Lesser GJ, Shaw EG. Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Aug 20;36(24):2473-2482. Epub 2018 Jul 10. PMID: 29989859
  • McLouth LE, Nightingale CL, Dressler EV, Snavely AC, Hudson MF, Unger JM, Kazak AE, Lee SJC, Edward J, Carlos R, Kamen CS, Neuman HB, Weaver KE. Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2021 Apr;30(4):669-675. Epub 2020 Dec 21. PMID: 33355237
  • Page BR, Shaw EG, Lu L, Bryant D, Grisell D, Lesser GJ, Monitto DC, Naughton MJ, Rapp SR, Savona SR, Shah S, Case D, Chan MD. Phase II double-blind placebo-controlled randomized study of armodafinil for brain radiation-induced fatigue. Neuro-oncology. 2015 Oct;17(10):1393-401. Epub 2015 May 12. PMID: 25972454
  • Lesser GJ, Irby MB, Taylor RC, Snavely A, Case D, Wang A, Dietrich A, Duncan S. Lactoferrin supplementation for taste and smell abnormalities among patients receiving cancer chemotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022 Mar;30(3):2017-2025. Epub 2021 Oct 13. PMID: 34642792
  • Jordan JH, Vasu S, Morgan TM, D'Agostino RB Jr, Meléndez GC, Hamilton CA, Arai AE, Liu S, Liu CY, Lima JA, Bluemke DA, Burke GL, Hundley WG. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors. Circulation. Cardiovascular imaging. 2016 Aug;9. (8). PMID: 27502058
  • Williams GR, Weaver KE, Lesser GJ, Dressler E, Winkfield KM, Neuman HB, Kazak AE, Carlos R, Gansauer LJ, Kamen CS, Unger JM, Mohile SG, Klepin HD. Capacity to Provide Geriatric Specialty Care for Older Adults in Community Oncology Practices. The oncologist. 2020 Dec;25(12):1032-1038. Epub 2020 Aug 31. PMID: 32820842
  • Cathcart-Rake EJ, Zemla T, Jatoi A, Weaver KE, Neuman H, Kazak AE, Carlos R, Gansauer L, Unger JM, Pajewski NM, Kamen C. Acquisition of sexual orientation and gender identity data among NCI Community Oncology Research Program practice groups. Cancer. 2019 Apr 15;125(8):1313-1318. Epub 2018 Dec 18. PMID: 30561776
  • Raja SN, Carr DB, Cohen M, Finnerup NB, Flor H, Gibson S, Keefe FJ, Mogil JS, Ringkamp M, Sluka KA, Song XJ, Stevens B, Sullivan MD, Tutelman PR, Ushida T, Vader K. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020 Sep 1;161(9):1976-1982. PMID: 32694387
  • Lamar ZS, Dothard A, Kennedy L, Isom S, Robinson M, Vaidya R, Hurd D, McClain D, Lesser G. Hyperglycemia during first-line R-CHOP or dose adjusted R-EPOCH chemotherapy for non-Hodgkin lymphoma is prevalent and associated with chemotherapy alteration - a retrospective study. Leukemia & lymphoma. 2018 Aug;59(8):1871-1877. Epub 2017 Dec 18. PMID: 29252084
  • Lawrence JA, Griffin L, Balcueva EP, Groteluschen DL, Samuel TA, Lesser GJ, Naughton MJ, Case LD, Shaw EG, Rapp SR. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy. Journal of cancer survivorship : research and practice. 2016 Feb;10(1):176-84. Epub 2015 Jul 1. PMID: 26130292
  • Danhauer SC, Griffin LP, Avis NE, Sohl SJ, Jesse MT, Addington EL, Lawrence JA, Messino MJ, Giguere JK, Lucas SL, Wiliford SK, Shaw E. Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer. The Journal of community and supportive oncology. 2015 Apr;13(4):139-147. PMID: 28713846
  • Wong SS, Case LD, Avis NE, Cummings TL, Cramer CK, Rapp SR. Cognitive functioning following brain irradiation as part of cancer treatment: Characterizing better cognitive performance. Psycho-oncology. 2019 Nov;28(11):2166-2173. Epub 2019 Aug 30. PMID: 31418491
  • Bhatt VR, Ulrich AM, Uy GL, Stone RM, Stock W, Ojelabi MO, Yin J, Kohlschmidt J, Eisfeld AK, Baer MR, Chow S, Klepin H, Le-Rademacher J, Jatoi A. Outcomes of Older Adults With AML Treated in Community Versus Academic Centers: An Analysis of Alliance Trials. JCO oncology practice. 2023 Jun;19(6):e877-e891. Epub 2023 Apr 14. PMID: 37058684
  • Carlos RC, Sicks JD, Chiles C, Gansauer L, Kamen CS, Kazak AE, Neuman HB, Unger JM, Weaver KE. Lung Cancer Screening in the National Cancer Institute Community Oncology Research Program: Availability and Service Organization. Journal of the American College of Radiology : JACR. 2019 Apr;16(4 Pt A):427-434. Epub 2019 Feb 26. PMID: 30819455
  • Okoukoni C, McTyre ER, Ayala Peacock DN, Peiffer AM, Strowd R, Cramer C, Hinson WH, Rapp S, Metheny-Barlow L, Shaw EG, Chan MD. Hippocampal dose volume histogram predicts Hopkins Verbal Learning Test scores after brain irradiation. Advances in radiation oncology. 2017 Aug 30;2(4):624-629. doi: 10.1016/j.adro.2017.08.013. eCollection 2017 Oct-Dec. PMID: 29204530
  • Lyu Q, Shan H, Steber C, Helis C, Whitlow C, Chan M, Wang G. Multi-Contrast Super-Resolution MRI Through a Progressive Network. IEEE transactions on medical imaging. 2020 Sep;39(9):2738-2749. Epub 2020 Feb 18. PMID: 32086201
  • Foley KL, Miller DP Jr, Weaver K, Sutfin EL, Petty WJ, Bellinger C, Spangler J, Stone RJ, Lawler D, Davis W, Dressler E, Lesser G, Chiles C. The OaSiS trial: A hybrid type II, national cluster randomized trial to implement smoking cessation during CT screening for lung cancer. Contemporary clinical trials. 2020 Apr;91:105963. Epub 2020 Feb 20. PMID: 32087340
  • Hughes RT, Ip EH, Urbanic JJ, Hu JJ, Weaver KE, Lively MO, Winkfield KM, Shaw EG, Diaz LB, Brown DR, Strasser J, Sears JD, Lesser GJ. Smoking and Radiation-induced Skin Injury: Analysis of a Multiracial, Multiethnic Prospective Clinical Trial. Clinical breast cancer. 2022 Dec;22(8):762-770. Epub 2022 Sep 16. PMID: 36216768
  • Gilam G, Gross JJ, Wager TD, Keefe FJ, Mackey SC. What Is the Relationship between Pain and Emotion? Bridging Constructs and Communities. Neuron. 2020 Jul 8;107(1):17-21. Epub 2020 Jun 19. PMID: 32562660
  • Datta M, Shaw EG, Lesser GJ, Case LD, Vitolins MZ, Schneider C, Frizzell B, Sullivan C, Lively M, Franzmann E, Hu JJ. A Randomized Double-Blind Placebo-Controlled Trial of Fruit and Vegetable Concentrates on Intermediate Biomarkers in Head and Neck Cancer. Integrative cancer therapies. 2018 Mar;17(1):115-123. Epub 2017 Jan 19. PMID: 28102098
  • Ozga M, Nicolet D, Mrózek K, Yilmaz AS, Kohlschmidt J, Larkin KT, Blachly JS, Oakes CC, Buss J, Walker CJ, Orwick S, Jurinovic V, Rothenberg-Thurley M, Dufour A, Schneider S, Sauerland MC, Görlich D, Krug U, Berdel WE, Woermann BJ, Hiddemann W, Braess J, Subklewe M, Spiekermann K, Carroll AJ, Blum WG, Powell BL, Kolitz JE, Moore JO, Mayer RJ, Larson RA, Uy GL, Stock W, Metzeler KH, Grimes HL, Byrd JC, Salomonis N, Herold T, Mims AS, Eisfeld AK. Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG). Leukemia. 2024 Jan;38(1):45-57. Epub 2023 Nov 28. PMID: 38017103
  • Mrózek K, Kohlschmidt J, Blachly JS, Nicolet D, Carroll AJ, Archer KJ, Mims AS, Larkin KT, Orwick S, Oakes CC, Kolitz JE, Powell BL, Blum WG, Marcucci G, Baer MR, Uy GL, Stock W, Byrd JC, Eisfeld AK. Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study. Leukemia. 2023 Apr;37(4):788-798. Epub 2023 Feb 23. PMID: 36823396
  • Weaver KE, Klepin HD, Wells BJ, Dressler EV, Winkfield KM, Lamar ZS, Avery TP, Pajewski NM, Hundley WG, Johnson A, Davidson EC, Lopetegui M, Foraker RE. Cardiovascular Assessment Tool for Breast Cancer Survivors and Oncology Providers: Usability Study. JMIR cancer. 2021 Jan 21;7(1):e18396. PMID: 33475511
  • Greven KM, Case LD, Nycum LR, Zekan PJ, Hurd DD, Balcueva EP, Mills GM, Zon R, Flynn PJ, Biggs D, Shaw EG, Lesser G, Naughton MJ. Effect of ArginMax on sexual functioning and quality of life among female cancer survivors: results of the WFU CCOP Research Base Protocol 97106. The Journal of community and supportive oncology. 2015 Mar;13(3):87-94. PMID: 26287032
  • Bogart J, Wang X, Masters G, Gao J, Komaki R, Gaspar LE, Heymach J, Bonner J, Kuzma C, Waqar S, Petty W, Stinchcombe TE, Bradley JD, Vokes E. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2023 May 1;41(13):2394-2402. Epub 2023 Jan 9. PMID: 36623230
  • Nightingale C, Sterba KR, Levine B, Tooze JA, Greven K, Frizzell B, Hughes RT, Snavely A, Lesser GJ, Norona S, Pleasant K, Weaver KE. Feasibility and Acceptability of a Multi-Modality Self-Management Intervention for Head and Neck Cancer Caregivers: A Pilot Randomized Trial. Integrative cancer therapies. 2022 Jan-Dec;21:15347354221098984. PMID: 35575280
  • Faro JM, Dressler EV, Kittel C, Beeler DM, Bluethmann SM, Sohl SJ, McDonald AM, Weaver KE, Nightingale C, Landscape Committee, Neuman HB, Nightingale CL, Parsons SK, Obeng-Gyasi S, Cooley ME, Loh KP, Ramsey SD, McDonald AM, Foust M, Braun-Inglis C, Kyono WT, Drescher CW, Wood EG, Dressler EV. Availability of cancer survivorship support services across the National Cancer Institute Community Oncology Research Program network. JNCI cancer spectrum. 2024 Jan 4;8. (1). PMID: 38268476
  • Nightingale CL, Snavely AC, McLouth LE, Dressler EV, Kent EE, Adonizio CS, Danhauer SC, Cannady R, Hopkins JO, Kehn H, Weaver KE, Sterba KR. Processes for identifying caregivers and screening for caregiver and patient distress in community oncology: results from WF-1803CD. Journal of the National Cancer Institute. 2024 Feb 8;116(2):324-333. PMID: 37738445
  • Carlos RC, Sicks JD, Chang GJ, Lyss AP, Stewart TL, Sung L, Weaver KE. Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners. Journal of the American College of Radiology : JACR. 2017 Dec;14(12):1530-1537. Epub 2017 Oct 19. PMID: 29055605

Clinical Trials

Study Name Clinical Trial ID
Testing Ramipril to Prevent Memory Loss in People With Glioblastoma NCT03475186
Work Ability in Young Adult Cancer Survivors NCT03148080
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil NCT02822573
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer NCT03963739
An Internet-based Program to Help Cancer Survivors Manage Pain NCT04462302
Stepped-Care Telehealth for Distress in Cancer Survivors NCT03060096
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices NCT03746314
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy NCT05703269
Reducing Lung Cancer-Related Anxiety (RELAX) NCT02063828
Mobile-Health Delivery of Lifestyle Interventions for Women With Breast Cancer NCT05132296
Food Insecurity in Oncology NCT05176743